48 related articles for article (PubMed ID: 31435431)
21. [Concurrent control study of different radiotherapy for primary nasopharyngeal carcinoma: intensity-modulated radiotherapy versus conventional radiotherapy].
Zhang Y; Lin ZA; Pan JJ; Zheng Z; Yang L; Lin SJ; Zheng F
Ai Zheng; 2009 Nov; 28(11):1143-8. PubMed ID: 19895733
[TBL] [Abstract][Full Text] [Related]
22. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225.
Lee N; Harris J; Garden AS; Straube W; Glisson B; Xia P; Bosch W; Morrison WH; Quivey J; Thorstad W; Jones C; Ang KK
J Clin Oncol; 2009 Aug; 27(22):3684-90. PubMed ID: 19564532
[TBL] [Abstract][Full Text] [Related]
23. Brachytherapy boost for T1/T2 nasopharyngeal carcinoma.
Yeo R; Fong KW; Hee SW; Chua ET; Tan T; Wee J
Head Neck; 2009 Dec; 31(12):1610-8. PubMed ID: 19536853
[TBL] [Abstract][Full Text] [Related]
24. Sequential external beam radiotherapy and high-dose-rate intracavitary brachytherapy in T1 and T2 nasopharyngeal carcinoma: an evaluation of long-term outcome.
Thiagarajan A; Lin K; Tiong CE; Tan LK; Loh TK; Goh BC; Lu JJ
Laryngoscope; 2006 Jun; 116(6):938-43. PubMed ID: 16735885
[TBL] [Abstract][Full Text] [Related]
25. Nasopharyngeal carcinoma treated by radical radiotherapy alone: Ten-year experience of a single institution.
Yi JL; Gao L; Huang XD; Li SY; Luo JW; Cai WM; Xiao JP; Xu GZ
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):161-8. PubMed ID: 16542792
[TBL] [Abstract][Full Text] [Related]
26. Nasopharyngeal intracavitary brachytherapy: the controversy of T2b disease.
Leung TW; Tung SY; Wong VY; Sze WK; Lui CM; Wong FC; Lee AS; O SK
Cancer; 2005 Oct; 104(8):1648-55. PubMed ID: 16118806
[TBL] [Abstract][Full Text] [Related]
27. Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group.
Yu KH; Leung SF; Tung SY; Zee B; Chua DT; Sze WM; Law SC; Kam MK; Leung TW; Sham JS; Lee AW; Au JS; Hui EP; Sze WK; Cheng AC; Yau TK; Ngan RK; Wong FC; Au GK; Chan AT;
Head Neck; 2005 May; 27(5):397-405. PubMed ID: 15726589
[TBL] [Abstract][Full Text] [Related]
28. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
[TBL] [Abstract][Full Text] [Related]
29. Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function.
Kwong DL; Pow EH; Sham JS; McMillan AS; Leung LH; Leung WK; Chua DT; Cheng AC; Wu PM; Au GK
Cancer; 2004 Oct; 101(7):1584-93. PubMed ID: 15378492
[TBL] [Abstract][Full Text] [Related]
30. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience.
Lee N; Xia P; Quivey JM; Sultanem K; Poon I; Akazawa C; Akazawa P; Weinberg V; Fu KK
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):12-22. PubMed ID: 12007936
[TBL] [Abstract][Full Text] [Related]
31. Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma.
Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; O SK
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):405-12. PubMed ID: 10802367
[TBL] [Abstract][Full Text] [Related]
32. The time course of histologic remission after treatment of patients with nasopharyngeal carcinoma.
Kwong DL; Nicholls J; Wei WI; Chua DT; Sham JS; Yuen PW; Cheng AC; Wan KY; Kwong PW; Choy DT
Cancer; 1999 Apr; 85(7):1446-53. PubMed ID: 10193933
[TBL] [Abstract][Full Text] [Related]
33. Locally recurrent nasopharyngeal carcinoma: treatment results for patients with computed tomography assessment.
Chua DT; Sham JS; Kwong DL; Wei WI; Au GK; Choy D
Int J Radiat Oncol Biol Phys; 1998 May; 41(2):379-86. PubMed ID: 9607354
[TBL] [Abstract][Full Text] [Related]
34. How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?
Teo PM; Kwan WH; Chan AT; Lee WY; King WW; Mok CO
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):897-913. PubMed ID: 9531376
[TBL] [Abstract][Full Text] [Related]
35. Reirradiation for recurrent nasopharyngeal carcinoma: factors affecting the therapeutic ratio and ways for improvement.
Lee AW; Foo W; Law SC; Poon YF; Sze WM; O SK; Tung SY; Lau WH
Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):43-52. PubMed ID: 9212003
[TBL] [Abstract][Full Text] [Related]
36. Transpalatal insertion of radioactive gold grain for the treatment of persistent and recurrent nasopharyngeal carcinoma.
Choy D; Sham JS; Wei WI; Ho CM; Wu PM
Int J Radiat Oncol Biol Phys; 1993 Feb; 25(3):505-12. PubMed ID: 8382202
[TBL] [Abstract][Full Text] [Related]
37. Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985: survival after local recurrence.
Lee AW; Law SC; Foo W; Poon YF; Cheung FK; Chan DK; Tung SY; Thaw M; Ho JH
Int J Radiat Oncol Biol Phys; 1993 Aug; 26(5):773-82. PubMed ID: 8344845
[TBL] [Abstract][Full Text] [Related]
38. Dose-response analysis for nasopharyngeal carcinoma: an historical perspective.
Marks JE; Bedwinek JM; Lee F; Purdy JA; Perez CA
Cancer; 1982 Sep; 50(6):1042-50. PubMed ID: 7104948
[TBL] [Abstract][Full Text] [Related]
39. Patterns of failure in carcinoma of the nasopharynx: I. Failure at the primary site.
Vikram B; Mishra UB; Strong EW; Manolatos S
Int J Radiat Oncol Biol Phys; 1985 Aug; 11(8):1455-9. PubMed ID: 3926733
[TBL] [Abstract][Full Text] [Related]
40. Management of local residual primary lesion of nasopharyngeal carcinoma (NPC): are higher doses beneficial?
Yan JH; Qin DX; Hu YH; Cai WM; Xu GZ; Wu XL; Li SY; Gu XZ
Int J Radiat Oncol Biol Phys; 1989 Jun; 16(6):1465-9. PubMed ID: 2498240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
